Accessed April 1, 2023
Topical: Why the Injectable Route Stands Out GHK-Cu is available in both topical and injectable forms, and both have their place
Despite the effectiveness of current treatments for weight management, some individuals will not reach the therapeutic goals that are associated with greater body weight reduction, Sean Wharton, MD, FRCPC, PharmD, medical director of the Wharton Medical Clinic, assistant professor at the University of Toronto and adjunct professor at both McMaster University in Hamilton, Ontario, and York University in Toronto, and colleagues wrote in the STEP UP publication
While Tirzepatide is commonly studied for dual receptor activity involving GLP-1 and GIP pathways, Retatrutide is often researched because of its additional receptor interactions
Dehydration and Electrolyte Imbalance : Gastrointestinal side effectsespecially nausea, vomiting, and diarrheacan lead to fluid and electrolyte losses
In addition to stimulating the release of insulin, GLP-1 agonists also appear to curb hunger and delay gastric emptying, leading to potential weight loss